INSIDER
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

Robinhood Chain…
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
Search

All disclosures

Every ingested record across SEC Form 4, 13F, House PTRs and Robinhood Chain, searchable by ticker, name or wallet address.

Results

Data sources
SEC Form 45h ago
House PTR5h ago
SEC 13F5h ago
Robinhood Chain5h ago

Results

78,781 records
Side
allbuysell
Score
any≥ 30≥ 50≥ 70
Sort
Newest disclosedNewest executedInsider ScoreValue
Include
grants & admin
ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
9
MS
Morris SusanDirector, Chief Executive Officer
ACIAlbertsons Companies, Inc.
Tax withholding
F—
17.5K sh
Apr 21, 2026Apr 23, 2026
Page 1124 of 1970
← PrevNext →
traded Apr 21, 2026
+2d
SEC Form 4

Evidence

9
TA
Tamboli AjimChief Financial Officer
TRAXFirst Tracks Biotherapeutics, Inc.
Grant or award
A—
41.2K sh
Apr 21, 2026Apr 23, 2026
traded Apr 21, 2026
+2dSEC Form 4

Evidence

9
VM
Vasconcelles MichaelHead of Research and Dev.
DAWNDay One Biopharmaceuticals, Inc.
Disposition to issuer
D—
226.0K sh
Apr 23, 2026Apr 23, 2026
traded Apr 23, 2026
+0dSEC Form 4

Evidence

9
RE
Rainwater EvanEVP, Supp. Chain, Mfg. & Sourc
ACIAlbertsons Companies, Inc.
Option exercise
M—
13.6K sh
Apr 21, 2026Apr 23, 2026
traded Apr 21, 2026
+2dSEC Form 4

Evidence

9
BJ
Bender JeremyDirector, CHIEF EXECUTIVE OFFICER
DAWNDay One Biopharmaceuticals, Inc.
Disposition to issuer
D—
244.0K sh
Apr 23, 2026Apr 23, 2026
traded Apr 23, 2026
+0dSEC Form 4

Evidence

9
DA
Dubow AdamGen Counsel & Secretary
DAWNDay One Biopharmaceuticals, Inc.
Disposition to issuer
D—
90.0K sh
Apr 23, 2026Apr 23, 2026
traded Apr 23, 2026
+0dSEC Form 4

Evidence

9
YN
York Charles N IICOO and CFO
DAWNDay One Biopharmaceuticals, Inc.
Disposition to issuer
D—
162.0K sh
Apr 23, 2026Apr 23, 2026
traded Apr 23, 2026
+0dSEC Form 4

Evidence

9
DJ
Dable Habib JDirector
DAWNDay One Biopharmaceuticals, Inc.
Disposition to issuer
D—
66.7K sh
Apr 23, 2026Apr 23, 2026
traded Apr 23, 2026
+0dSEC Form 4

Evidence

9
DA
Dubow AdamGen Counsel & Secretary
DAWNDay One Biopharmaceuticals, Inc.
Disposition to issuer
D—
8,889 sh
Apr 23, 2026Apr 23, 2026
traded Apr 23, 2026
+0dSEC Form 4

Evidence

9
WM
Withers MichaelEVP Retail Operations West
ACIAlbertsons Companies, Inc.
Option exercise
M—
6,692 sh
Apr 21, 2026Apr 23, 2026
traded Apr 21, 2026
+2dSEC Form 4

Evidence

9
DA
Dubow AdamGen Counsel & Secretary
DAWNDay One Biopharmaceuticals, Inc.
Disposition to issuer
D—
90.0K sh
Apr 23, 2026Apr 23, 2026
traded Apr 23, 2026
+0dSEC Form 4

Evidence

9
NA
Nicholson Garry ADirector
DAWNDay One Biopharmaceuticals, Inc.
Disposition to issuer
D—
32.3K sh
Apr 23, 2026Apr 23, 2026
traded Apr 23, 2026
+0dSEC Form 4

Evidence

9
SI
Simonsson Beatrice IngmarieChief Digital Officer
PSNYPolestar Automotive Holding UK PLC
Option exercise
M—
953 sh
Apr 21, 2026Apr 23, 2026
traded Apr 21, 2026
+2dSEC Form 4

Evidence

9
MM
Mindlin Marcos MarceloDirector, 10% Owner
PAMPampa Energy Inc.
Derivative conversion
C—
500.0K sh
Apr 21, 2026Apr 23, 2026
traded Apr 21, 2026
+2dSEC Form 4

Evidence

9
BJ
Bender JeremyDirector, CHIEF EXECUTIVE OFFICER
DAWNDay One Biopharmaceuticals, Inc.
Disposition to issuer
D—
286.0K sh
Apr 23, 2026Apr 23, 2026
traded Apr 23, 2026
+0dSEC Form 4

Evidence

9
SD
Satz DevinDirector
FVCBFVCBankcorp, Inc.
Grant or award
A—
2,000 sh
Apr 22, 2026Apr 23, 2026
traded Apr 22, 2026
+1dSEC Form 4

Evidence

9
TM
Testa Daniel M.Director
FVCBFVCBankcorp, Inc.
Grant or award
A—
2,000 sh
Apr 22, 2026Apr 23, 2026
traded Apr 22, 2026
+1dSEC Form 4

Evidence

9
DA
Dhanda AnujChief Tech &Transformation Off
ACIAlbertsons Companies, Inc.
Tax withholding
F—
12.9K sh
Apr 21, 2026Apr 23, 2026
traded Apr 21, 2026
+2dSEC Form 4

Evidence

9
TA
Tamboli AjimChief Financial Officer
TRAXFirst Tracks Biotherapeutics, Inc.
Grant or award
A—
45.7K sh
Apr 21, 2026Apr 23, 2026
traded Apr 21, 2026
+2dSEC Form 4

Evidence

9
SJ
St George Martin JPresident
JBLUJETBLUE AIRWAYS CORP
Grant or award
A—
274.7K sh
Apr 22, 2026Apr 23, 2026
traded Apr 22, 2026
+1dSEC Form 4

Evidence

9
PR
Petrino RichardDirector
NTRSNORTHERN TRUST CORP
Grant or award
A$2,997
17 sh
Apr 21, 2026Apr 23, 2026
traded Apr 21, 2026
+2dSEC Form 4

Evidence

9
MP
McCarthy Eileen PGeneral Counsel Corp Sec
JBLUJETBLUE AIRWAYS CORP
Grant or award
A—
91.6K sh
Apr 22, 2026Apr 23, 2026
traded Apr 22, 2026
+1dSEC Form 4

Evidence

9
JA
Josey John A.Director
DAWNDay One Biopharmaceuticals, Inc.
Disposition to issuer
D—
22.5K sh
Apr 23, 2026Apr 23, 2026
traded Apr 23, 2026
+0dSEC Form 4

Evidence

9
JA
Josey John A.Director
DAWNDay One Biopharmaceuticals, Inc.
Disposition to issuer
D—
1,181 sh
Apr 23, 2026Apr 23, 2026
traded Apr 23, 2026
+0dSEC Form 4

Evidence

9
ML
Merendino LaurenChief Commercial Officer
DAWNDay One Biopharmaceuticals, Inc.
Disposition to issuer
D—
19.0K sh
Apr 23, 2026Apr 23, 2026
traded Apr 23, 2026
+0dSEC Form 4

Evidence

9
VM
Vasconcelles MichaelHead of Research and Dev.
DAWNDay One Biopharmaceuticals, Inc.
Disposition to issuer
D—
171.0K sh
Apr 23, 2026Apr 23, 2026
traded Apr 23, 2026
+0dSEC Form 4

Evidence

9
ML
Merendino LaurenChief Commercial Officer
DAWNDay One Biopharmaceuticals, Inc.
Disposition to issuer
D—
90.0K sh
Apr 23, 2026Apr 23, 2026
traded Apr 23, 2026
+0dSEC Form 4

Evidence

9
DH
Dhruv Anuj HasitEVP and CFO
WFRDWeatherford International plc
Option exercise
M—
11.2K sh
Apr 21, 2026Apr 23, 2026
traded Apr 21, 2026
+2dSEC Form 4

Evidence

9
DA
Dubow AdamGen Counsel & Secretary
DAWNDay One Biopharmaceuticals, Inc.
Disposition to issuer
D—
5,250 sh
Apr 23, 2026Apr 23, 2026
traded Apr 23, 2026
+0dSEC Form 4

Evidence

9
TB
Thompson Teresa BrigidDirector
SNYRSynergy CHC Corp.
Grant or award
A—
25.8K sh
Apr 21, 2026Apr 23, 2026
traded Apr 21, 2026
+2dSEC Form 4

Evidence

9
ML
Merendino LaurenChief Commercial Officer
DAWNDay One Biopharmaceuticals, Inc.
Disposition to issuer
D—
25.8K sh
Apr 23, 2026Apr 23, 2026
traded Apr 23, 2026
+0dSEC Form 4

Evidence

9
VM
Vasconcelles MichaelHead of Research and Dev.
DAWNDay One Biopharmaceuticals, Inc.
Disposition to issuer
D—
346.0K sh
Apr 23, 2026Apr 23, 2026
traded Apr 23, 2026
+0dSEC Form 4

Evidence

9
GW
Grossman WilliamDirector
DAWNDay One Biopharmaceuticals, Inc.
Disposition to issuer
D—
66.7K sh
Apr 23, 2026Apr 23, 2026
traded Apr 23, 2026
+0dSEC Form 4

Evidence

9
CA
Clements Carol AnnChief Digital & Tech Officer
JBLUJETBLUE AIRWAYS CORP
Grant or award
A—
160.3K sh
Apr 22, 2026Apr 23, 2026
traded Apr 22, 2026
+1dSEC Form 4

Evidence

9
HM
Harrison Dean MDirector
NTRSNORTHERN TRUST CORP
Grant or award
A$5,992
35 sh
Apr 21, 2026Apr 23, 2026
traded Apr 21, 2026
+2dSEC Form 4

Evidence

9
SS
Sharma SanjaySee Remarks*
SEICSEI INVESTMENTS CO
Option exercise
M—
12.5K sh
Apr 23, 2026Apr 23, 2026
traded Apr 23, 2026
+0dSEC Form 4

Evidence

9
GJ
Geraghty JoannaDirector, CEO
JBLUJETBLUE AIRWAYS CORP
Grant or award
A—
446.4K sh
Apr 22, 2026Apr 23, 2026
traded Apr 22, 2026
+1dSEC Form 4

Evidence

9
JA
Josey John A.Director
DAWNDay One Biopharmaceuticals, Inc.
Disposition to issuer
D—
28.7K sh
Apr 23, 2026Apr 23, 2026
traded Apr 23, 2026
+0dSEC Form 4

Evidence

9
BJ
Bender JeremyDirector, CHIEF EXECUTIVE OFFICER
DAWNDay One Biopharmaceuticals, Inc.
Disposition to issuer
D—
300.0K sh
Apr 23, 2026Apr 23, 2026
traded Apr 23, 2026
+0dSEC Form 4

Evidence

9
HL
Henderson Jay LDirector
NTRSNORTHERN TRUST CORP
Grant or award
A—
989 sh
Apr 21, 2026Apr 23, 2026
traded Apr 21, 2026
+2dSEC Form 4

Evidence